Euro Roundup: Swissmedic updates responsible person document, asks for immediate action - Regulat...

Euro Roundup: Swissmedic updates responsible person document, asks for immediate action  Regulatory Focus

Swissmedic Cracks Down on Vague Drug Indications & Tightens Assessments Of CCI Claims - Pink Sheet

Swissmedic Cracks Down on Vague Drug Indications & Tightens Assessments Of CCI Claims  Pink Sheet

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution -...

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution  Swissmedic

Euro Roundup: Swissmedic revises four medicines authorization guidances - Regulatory Focus

Euro Roundup: Swissmedic revises four medicines authorization guidances  Regulatory Focus

Swissmedic Asks Sponsors For At Least Four Months’ Notice Ahead Of New Drug Filings - Pink Sheet

Swissmedic Asks Sponsors For At Least Four Months’ Notice Ahead Of New Drug Filings  Pink Sheet

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections - SWI swissinfo.ch in En...

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections  SWI swissinfo.ch in English

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine - Reuters

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine  Reuters

Pharmacogenetic information in Swiss drug labels – a systematic analysis - Nature.com

Pharmacogenetic information in Swiss drug labels – a systematic analysis  Nature.com

Eva von Mühlenen - Sidley Austin LLP

Eva von Mühlenen  Sidley Austin LLP

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility ...

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland  Biogen | Investor Relations

Euro Roundup: Swissmedic seeks feedback on ICH real-world drug safety data guidance - Regulatory ...

Euro Roundup: Swissmedic seeks feedback on ICH real-world drug safety data guidance  Regulatory Focus

What’s Happening in the UK and Switzerland - MedTech Intelligence

What’s Happening in the UK and Switzerland  MedTech Intelligence

Pharmaceutical Advertising Laws and Regulations Report 2024 Switzerland - ICLG.com

Pharmaceutical Advertising Laws and Regulations Report 2024 Switzerland  ICLG.com

Masitinib Gains Orphan Drug Status for ALS in Switzerland - ALS News Today

Masitinib Gains Orphan Drug Status for ALS in Switzerland  ALS News Today

Swissmedic authorises new drug for respiratory disease - SWI swissinfo.ch in English

Swissmedic authorises new drug for respiratory disease  SWI swissinfo.ch in English

Meandering between two worlds - Visible - Swissmedic

Meandering between two worlds - Visible  Swissmedic

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal p...

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products  Swissmedic

Euro Roundup: Switzerland updates legislation to improve clinical trial framework - Regulatory Focus

Euro Roundup: Switzerland updates legislation to improve clinical trial framework  Regulatory Focus

Hemophilia B gene therapy Hemgenix approved in Switzerland - Hemophilia News Today

Hemophilia B gene therapy Hemgenix approved in Switzerland  Hemophilia News Today

Swiss New Drug Approval Times On A Par With EMA, But Longer Than US FDA - Pink Sheet

Swiss New Drug Approval Times On A Par With EMA, But Longer Than US FDA  Pink Sheet

Switzerland and US sign drug inspection agreement - European Pharmaceutical Review

Switzerland and US sign drug inspection agreement  European Pharmaceutical Review

Swissmedic Approves Zambon and Newron Therapy against Parkinson’s - Labiotech.eu

Swissmedic Approves Zambon and Newron Therapy against Parkinson’s  Labiotech.eu

Switzerland: Revision of Narcotics Act – Switzerland fully legalizes medicinal cannabis - GlobalC...

Switzerland: Revision of Narcotics Act – Switzerland fully legalizes medicinal cannabis  GlobalComplianceNews

US and Switzerland sign good manufacturing practice agreement - BioPharma-Reporter.com

US and Switzerland sign good manufacturing practice agreement  BioPharma-Reporter.com

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the...

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy  PR Newswire

Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the...

Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy  StockTitan

Journey of blood - Visible - Swissmedic

Journey of blood - Visible  Swissmedic

Switzerland Delays AstraZeneca Vaccine Approval, Wanting More Data - BioSpace

Switzerland Delays AstraZeneca Vaccine Approval, Wanting More Data  BioSpace

VMD and Swissmedic agree collaboration on veterinary medicinal products - GOV.UK

VMD and Swissmedic agree collaboration on veterinary medicinal products  GOV.UK

Falsified Ozempic diabetes medication in circulation - Swissmedic

Falsified Ozempic diabetes medication in circulation  Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal pr...

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal products  Swissmedic

Inadequate monitoring - Public Eye

Inadequate monitoring  Public Eye

Swissmedic Sees Spike in Adverse Event Reports for Third Straight Year - Regulatory Focus

Swissmedic Sees Spike in Adverse Event Reports for Third Straight Year  Regulatory Focus

Swissmedic and the Korean regulatory authority extend their cooperation in the area of therapeuti...

Swissmedic and the Korean regulatory authority extend their cooperation in the area of therapeutic products  Swissmedic

Consolidating veterinary medicinal product expertise - Swissmedic

Consolidating veterinary medicinal product expertise  Swissmedic

Covid 19 - Visible - Swissmedic

Covid 19 - Visible  Swissmedic

United Kingdom – Switzerland Regulatory Cooperation - GOV.UK

United Kingdom – Switzerland Regulatory Cooperation  GOV.UK

Travere Therapeutics Inc (TVTX-Q) Quote - Press Release - The Globe and Mail

Travere Therapeutics Inc (TVTX-Q) Quote - Press Release  The Globe and Mail

Meet René: The IDF’s First Ever Swiss-Bedouin Medic - idf.il

Meet René: The IDF’s First Ever Swiss-Bedouin Medic  idf.il

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

First Covid-19 vaccine approved for Swiss use - SWI swissinfo.ch in English

First Covid-19 vaccine approved for Swiss use  SWI swissinfo.ch in English

Switzerland approves Novavax’s Covid vaccine for 12-18 year olds - SWI swissinfo.ch in English

Switzerland approves Novavax’s Covid vaccine for 12-18 year olds  SWI swissinfo.ch in English

Switzerland approves vaccine that targets two Covid variants - SWI swissinfo.ch in English

Switzerland approves vaccine that targets two Covid variants  SWI swissinfo.ch in English

Interview with Raimund Bruhin, Executive Director of Swissmedic - Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic  Swissmedic

Switzerland’s drug approval process lags behind Europe - SWI swissinfo.ch in English

Switzerland’s drug approval process lags behind Europe  SWI swissinfo.ch in English

Minergie/sustainability - Visible - Swissmedic

Minergie/sustainability - Visible  Swissmedic

Breakthrough Alzheimer’s drug produced in Switzerland - SWI swissinfo.ch in English

Breakthrough Alzheimer’s drug produced in Switzerland  SWI swissinfo.ch in English

Interview with Swissmedic Agency Council Chair Lukas Bruhin - Swissmedic

Interview with Swissmedic Agency Council Chair Lukas Bruhin  Swissmedic

Committed to the next generation - Swissmedic

Committed to the next generation  Swissmedic

A lack of transparency - Public Eye

A lack of transparency  Public Eye

Swissmedic approves Lixiana for the prevention of stroke and systemic embolism in non-valvular at...

Swissmedic approves Lixiana for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation  European Pharmaceutical Review

When Are New Pharmaceuticals Too Expensive? - Avenir Suisse

When Are New Pharmaceuticals Too Expensive?  Avenir Suisse

Switzerland gives green light to Moderna’s Covid vaccine for 6-11 year olds - SWI swissinfo.ch in...

Switzerland gives green light to Moderna’s Covid vaccine for 6-11 year olds  SWI swissinfo.ch in English

Widespread hygiene deficiencies in Swiss hospitals - Le News

Widespread hygiene deficiencies in Swiss hospitals  Le News

Medical Devices - Visible - Swissmedic

Medical Devices - Visible  Swissmedic

Monkeypox medication not authorised in Switzerland - SWI swissinfo.ch in English

Monkeypox medication not authorised in Switzerland  SWI swissinfo.ch in English

New publication: "Cannabis" – A Handbook for Science and Practice - Swissmedic

New publication: "Cannabis" – A Handbook for Science and Practice  Swissmedic

Market surveillance - Visible - Swissmedic

Market surveillance - Visible  Swissmedic

Covid: Emergency vaccine approval not an option in Switzerland - Le News

Covid: Emergency vaccine approval not an option in Switzerland  Le News

Covid: Switzerland REFUSES to approve Oxford AstraZeneca vaccine - Daily Mail

Covid: Switzerland REFUSES to approve Oxford AstraZeneca vaccine  Daily Mail

Klinische Prüfungen mit Medizinprodukten - Swissmedic

Klinische Prüfungen mit Medizinprodukten  Swissmedic

The Shady Business Of Experimental Stem Cell Treatments - Worldcrunch

The Shady Business Of Experimental Stem Cell Treatments  Worldcrunch

Swissmedic uncovers shortcomings in Swiss hospitals - blue News

Swissmedic uncovers shortcomings in Swiss hospitals  blue News

Swissmedic identifies dangerous substances in slimming products claimed to be herbal - Swissmedic

Swissmedic identifies dangerous substances in slimming products claimed to be herbal  Swissmedic

Swissmedic identifies dangerous substances in slimming products claimed to be herbal - Swissmedic

Swissmedic identifies dangerous substances in slimming products claimed to be herbal  Swissmedic

Dangerous potency products obtained over the Internet - Swissmedic

Dangerous potency products obtained over the Internet  Swissmedic

REVLIMID® Granted Swissmedic Approval for Treatment of Rare Blood Cancer - elEconomista

REVLIMID® Granted Swissmedic Approval for Treatment of Rare Blood Cancer  elEconomista